Thermo Fisher announces collaboration with Precision Health Research

Thermo Fisher (TMO) Scientific announced a strategic collaboration with Precision Health Research, Singapore to advance the PRECISE-SG100K study, one of the region’s most ambitious and diverse population-scale biobank initiatives. The collaboration reflects growing investments from national population studies looking to harness proteomics to drive insight into real-time disease biology for application in earlier detection, prevention and personalized care. “Proteomics at population scale represents one of the most powerful opportunities to understand disease in real time across the full continuum of health,” said Marc Casper, chairman and chief executive officer of Thermo Fisher. “By combining our deep scientific expertise with industry-leading technologies, we are helping national health leaders translate complex biological data into insights that can fundamentally transform human health.”